Premier Alternatives

Clarametyx Biosciences

Columbus, OH · Founded 2019 · Privately Held (backing)

Developer of immune-facilitated biologic therapies designed to fight life-threatening infections. Clarametyx Biosciences is based in Columbus, OH and was founded in 2019. It was valued at $92 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $44 million across 1 recorded round; the latest was a $27.5 million early-stage round in Jan 2024.

PMV mark · valuation
$92.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$44.0M
Last round
Early Stage VC
Jan 2024

Clarametyx Biosciences key facts

as of Oct 2026
  • Developer of immune-facilitated biologic therapies designed to fight life-threatening infections.
  • Clarametyx Biosciences is valued at approximately $92.0M as of Oct 2026, set at its later-stage round, Jul 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $44.0M across 1 recorded rounds; the latest was Early Stage VC ($27.5M) in Jan 2024.
  • Notable investors include JobsOhio Ventures, Rev1 Ventures, CincyTech, CARB-X, Nationwide Children's Hospital — 8 tracked in total.
  • Clarametyx Biosciences has filed 1 Form D with the SEC, most recently Jan 2024 ($27.5M sold to 7 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$92.0M

Valued at $92.0M at its later-stage round, Jul 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Clarametyx Biosciences with a free account
  • ·Watch Clarametyx Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Clarametyx Biosciences funding rounds

1 rounds
Jan 2024Early Stage VC$27.5MSEC filing▮
Full funding history →

Clarametyx Biosciences valuation

Clarametyx Biosciences was valued at $92 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Clarametyx Biosciences raised?

Clarametyx Biosciences has raised $44 million in total; 1 of its rounds is on record. The largest on record was a $27.5 million early-stage round in Jan 2024.

Clarametyx Biosciences has filed 1 Form D with the SEC, most recently in Jan 2024 ($27.5 million sold to 7 investors).

Clarametyx Biosciences investors

8 investors are on record for Clarametyx Biosciences, including JobsOhio Ventures, Rev1 Ventures, CincyTech and CARB-X. The early-stage round in Jan 2024 drew 7 investors.

About Clarametyx Biosciences

Developer of immune-facilitated biologic therapies designed to fight life-threatening infections. The company's novel technology platform targets the protective barrier around bacteria through biological therapies, enabling healthcare professionals to target the challenging infections fueled by biofilms and reduce antibiotic resistance.

Sector
Healthcare
HQ
Columbus, OH, United States
Founded
2019
Employees
14
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.